focus
Previous article:
Cancer drug shortages should be causing more outrage
Next article: Listen: Biogen's potential pivot, & Illumina's next chapter
Next article: Listen: Biogen's potential pivot, & Illumina's next chapter
explore
hotspot
-
Prime Medicine, Myeloid Therapeutics clash over genome
2025-09-30 10:22 -
Medicare drug price negotiation hasn't dried up venture capital
2025-09-30 09:56 -
David Ricks of Eli Lilly: best biopharma CEO of 2023
2025-09-30 09:01 -
Weighted lottery helped low
2025-09-30 08:59 -
Bristol Myers buys into radiopharmaceuticals with RayzeBio
2025-09-30 08:28 -
Carvykti CAR
2025-09-30 08:10